N-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

Catalog No. :
ACAVRV335
CAS No. :
2096336-19-3
Molecular Formula :
C14H23BN2O2
Molecular Weight :
262.16

IUPAC Name:N-isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

N-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
IUPAC NameN-isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
Molecular FormulaC14H23BN2O2
Molecular Weight262.16
SMILESCC1(C)C(C)(C)OB(C2=CC(NC(C)C)=NC=C2)O1
InChI KeySWGCGKGVEGQKSX-UHFFFAOYSA-N
Synonym2-(Isopropylamino)pyridine-4-boronic acid pinacol ester;N-propan-2-YL-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-YL)pyridin-2-amine;N-(1-Methylethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine
CAS No.2096336-19-3

Safety Data

Pictogram
PICTURE
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACAVRV335 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDHWR716 route compound structure diagram
    ACDHWR71629552-58-7 In Stock
  2. Plus
  3. ACPNVO357 route compound structure diagram
    ACPNVO357458532-84-8 In Stock
  4. Then
  5. ACAVRV335 route product structure diagram
    ACAVRV3352096336-19-3
Inquiry

2. ACAVRV335 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACAVRV335 route product structure diagram
    ACAVRV3352096336-19-3
Inquiry

Comments (0)